Order Article Reprints

Jung R, Lehmann A, Knopp T, Molitor M, Perius K, Posma J, Garlapati V, Münzel T, Daiber A, Lurz P, et al. Antagonizing IL-17A Reduces Vascular Inflammation and Attenuates Oxidative Stress Formation but Does Not Significantly Improve Vascular Dysfunction Induced by One Week of Angiotensin II Treatment. Antioxidants. 2026; 15(2):229. https://doi.org/10.3390/antiox15020229

Jung, Rebecca, Annika Lehmann, Tanja Knopp, Michael Molitor, Katharina Perius, Jens Posma, Venkata Garlapati, Thomas Münzel, Andreas Daiber, Philipp Lurz, and et al. 2026. "Antagonizing IL-17A Reduces Vascular Inflammation and Attenuates Oxidative Stress Formation but Does Not Significantly Improve Vascular Dysfunction Induced by One Week of Angiotensin II Treatment" Antioxidants 15, no. 2: 229. https://doi.org/10.3390/antiox15020229

Jung, R., Lehmann, A., Knopp, T., Molitor, M., Perius, K., Posma, J., Garlapati, V., Münzel, T., Daiber, A., Lurz, P., Wenzel, P., Waisman, A., Wild, J., & Karbach, S. H. (2026). Antagonizing IL-17A Reduces Vascular Inflammation and Attenuates Oxidative Stress Formation but Does Not Significantly Improve Vascular Dysfunction Induced by One Week of Angiotensin II Treatment. Antioxidants, 15(2), 229. https://doi.org/10.3390/antiox15020229